Evidence map›Paper›PMID 32094203›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.

Rebecca J Henry, Rodney M Ritzel, James P Barrett, Sarah J Doran, Yun Jiao, Jennie B Leach, Gregory L Szeto, Junfang Wu, Bogdan A Stoica, Alan I Faden and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 228 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
228citing papers in PubMed, 1 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

228 citing papers in PubMed, 1 synthesis or guideline pooled it, 334 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

168 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Rebecca J HenryDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201, rhenry@som.umaryland.edu loanedj@tcd.ie.
Rodney M RitzelDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.
James P BarrettDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Sarah J DoranDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Yun JiaoDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland, Baltimore County, Maryland 21250.
Jennie B LeachDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland, Baltimore County, Maryland 21250.
Gregory L SzetoDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland, Baltimore County, Maryland 21250.ORCID 0000-0001-7604-1333
Junfang WuDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Bogdan A StoicaDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.ORCID 0000-0002-2501-6434
Alan I FadenDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.
David J LoaneDepartment of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, Maryland 21201, rhenry@som.umaryland.edu loanedj@tcd.ie.ORCID 0000-0003-0393-3503
University of Maryland, Baltimore · USUniversity of Maryland, Baltimore County · US

Funding

MODULATION OF INJURY BY METABOTROPIC GLUTAMATE RECEPTORSR01NS037313 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI FADEN, ALAN IRA · 1999 to 2019
$5.8M
Reprogramming Microglial Epigenetic Pathways to Promote Cognitive Recovery after Brain Trauma.R01NS110756 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI FADEN, ALAN IRA, LOANE, DAVID J. · 2019 to 2023
$2.3M
miR-711 regulation of neuronal cell death after traumatic brain injuryR01NS096002 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI SABIRZHANOV, BORIS, STOICA, BOGDAN ADRIAN · 2016 to 2020
$1.7M
Microglial activation phenotypes and mechanisms of repair in the aged TBI brainR01NS082308 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI LOANE, DAVID J. · 2013 to 2016
$1.4M
A fully biological platform for monitoring mesoscale neural activityR21EY029451 · NEI · DUKE UNIVERSITY · PI DZIRASA, KAFUI · 2018 to 2019
$473k
Inhibition of chronic neuroinflammation reduces neurological deficits after TBII01RX001993 · VA · BALTIMORE VA MEDICAL CENTER · PI STOICA, BOGDAN ADRIAN · 2016 to 2020
–
NEI NIH HHS R21 EY029451NINDS NIH HHS R01 NS037313NINDS NIH HHS R01 NS082308NINDS NIH HHS R01 NS096002NINDS NIH HHS R01 NS110756RRD VA I01 RX001993
6 · The paper itself

Abstract

Chronic neuroinflammation with sustained microglial activation occurs following severe traumatic brain injury (TBI) and is believed to contribute to subsequent neurodegeneration and neurological deficits. Microglia, the primary innate immune cells in brain, are dependent on colony stimulating factor 1 receptor (CSF1R) signaling for their survival. In this preclinical study, we examined the effects of delayed depletion of chronically activated microglia on functional recovery and neurodegeneration up to 3 months postinjury. A CSF1R inhibitor, Plexxikon (PLX) 5622, was administered to adult male C57BL/6J mice at 1 month after controlled cortical impact to remove chronically activated microglia, and the inhibitor was withdrawn 1-week later to allow for microglial repopulation. Following TBI, the repopulated microglia displayed a ramified morphology similar to that of Sham uninjured mice, whereas microglia in vehicle-treated TBI mice showed the typical chronic posttraumatic hypertrophic morphology. PLX5622 treatment limited TBI-associated neuropathological changes at 3 months postinjury; these included a smaller cortical lesion, reduced hippocampal neuron cell death, and decreased NOX2- and NLRP3 inflammasome-associated neuroinflammation. Furthermore, delayed depletion of chronically activated microglia after TBI led to widespread changes in the cortical transcriptome and altered gene pathways involved in neuroinflammation, oxidative stress, and neuroplasticity. Using a variety of complementary neurobehavioral tests, PLX5622-treated TBI mice also had improved long-term motor and cognitive function recovery through 3 months postinjury. Together, these studies demonstrate that chronic phase removal of neurotoxic microglia after TBI using CSF1R inhibitors markedly reduce chronic neuroinflammation and associated neurodegeneration, as well as related motor and cognitive deficits.

Indexed as

AnimalsBrain Injuries, TraumaticDisease Models, AnimalMaleMiceMice, Inbred C57BLMicrogliaNerve DegenerationNeuroprotective AgentsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorCsf1r protein, mouseNeuroprotective AgentsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorCSF1Rfunctional recoverymicroglianeurodegenerationneuroinflammationtraumatic brain injury

Identifiers

PMID32094203
PMCPMC7117897
OpenAlexW3007134903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.